Neck surgery aims to drain Alzheimer's brain waste
NCT ID NCT07073066
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a surgical procedure called deep cervical lymphatic venous anastomosis (DC-LVA) in 376 people with moderate-to-severe Alzheimer's disease. The surgery connects lymph vessels in the neck to veins, aiming to improve drainage of waste from the brain. Researchers will compare cognitive decline over 12 months between those who get the surgery plus usual care and those who receive usual care alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Deep cervical lymphatic venous anastomosis (DC-LVA) surgery
- What this could lead to
- If it works, this surgery could slow cognitive decline in moderate-to-severe Alzheimer's disease by improving the brain's waste drainage.
- What could go wrong
- This is an early-stage surgical procedure with unknown long-term safety and efficacy. The trial is open-label, so both patients and doctors know who got the surgery, which can bias results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMERS DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hopital, Capital Medical University
RECRUITINGBeijing, 100070, China
-
Dongguan Chashan Hospital
RECRUITINGDongguan, Guangdong, China
-
First Affiliated Hospital of Shandong First Medical University
ACTIVE_NOT_RECRUITINGJinan, Shandong, 250000, China
-
Guangdong Second People's Hospital
RECRUITINGGuangdong, Guangzhou, 510000, China
-
Jining First People's Hospital
RECRUITINGJining, Shandong, 272000, China
-
Shandong Provincial Public Health Clinical Center
RECRUITINGJinan, Shandong, 250000, China
-
Shandong Provincial Third Hospital
RECRUITINGJinan, Shandong, 250000, China
-
The First Affiliated Hospital of Ningbo University
RECRUITINGNingbo, Zhejiang, 315000, China
-
Zhengzhou Central Hospital
RECRUITINGZhengzhou, Henan, 450000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Real-World data uncover hidden risks of the Alzheimer's drug LEQEMBI?
- Could a diabetes drug tame Alzheimer's inflammation?
- Nasal spray could tame brain inflammation in early Alzheimer's
- New drug aims to stop Alzheimer's before it starts in gene carriers
- Scientists hunt for molecular proof that music helps Alzheimer's patients
- Blood test aimed to speed up Alzheimer's diagnosis, but study was canceled